Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Ecora Royalties, Arrow Exploration, Buccaneer Energy, Powerhouse Energy, Solvonis Therapeutics, Genflow Biosciences - Small Cap Snapshot

Ecora Royalties, Arrow Exploration, Buccaneer Energy, Powerhouse Energy, Solvonis Therapeutics, Genflow Biosciences - Small Cap Snapshot

Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) just hit a major turning point with its critical minerals portfolio now outperforming its steelmaking coal assets. A massive boost in copper and cobalt helped the group pull in $57 million last year, with a $14.3 million contribution in the fourth quarter. Read more

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) has successfully brought its new Mateguafa 8 well in Colombia onto production. The company is already moving the rig to drill a new horizontal well at the site this month. Read more

Buccaneer Energy Plc (AIM:BUCE, FRA:LMU1) has grown its proved oil reserves by 6% following a fresh valuation review. This update keeps the company's $4.25 million credit facility steady despite more conservative oil price forecasts. Read more

Powerhouse Energy Group PLC (AIM:PHE, FRA:BT81) has officially submitted planning for a new waste-to-hydrogen plant at Ballymena in Northern Ireland. The facility aims to turn 40 tonnes of daily waste into pure hydrogen for local transport. Read more

Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF, FRA:J4I) is expanding its lead compound into depression research after seeing strong results in recent trials. The new drug outperformed a standard antidepressant in testing and targets mood and motivation. Watch more

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has secured €4 million in Belgian grant funding to develop its lead gene therapy. The cash injection will support its work on liver disease and ageing studies through 2026. Read more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK